Nexus Surgical and Medicare Limited (BOM:538874)
India · Delayed Price · Currency is INR 19.49
+1.30 (7.15%)
At close: Aug 21, 2026
BOM:538874 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 86.91 | 78.68 | 57.21 | 34.74 | 15.53 | 23.95 |
Other Revenue | 0.28 | - | - | - | - | - |
| 87.19 | 78.68 | 57.21 | 34.74 | 15.53 | 23.95 | |
Revenue Growth | 53.34% | 37.53% | 64.67% | 123.68% | -35.15% | -36.04% |
Cost of Revenue | 24.15 | 24.48 | 18.71 | 5.94 | 4.53 | - |
Gross Profit | 63.04 | 54.2 | 38.5 | 28.81 | 11 | 23.95 |
Selling, General & Admin | 2.94 | 3.15 | 4.07 | 2.4 | 2.51 | 2.24 |
Other Operating Expenses | 49.77 | 41.42 | 27.79 | 23.75 | 6.33 | 18.03 |
Operating Expenses | 52.75 | 44.61 | 31.89 | 26.17 | 8.85 | 20.3 |
Operating Income | 10.28 | 9.59 | 6.61 | 2.64 | 2.15 | 3.65 |
Interest & Investment Income | - | - | 0.07 | 0.26 | 0.14 | 0.22 |
Other Non Operating Income (Expenses) | 0.28 | 0.28 | - | 0 | 0 | 0.01 |
EBT Excluding Unusual Items | 10.57 | 9.88 | 6.68 | 2.91 | 2.29 | 3.88 |
Pretax Income | 10.57 | 9.88 | 6.68 | 2.91 | 2.29 | 3.88 |
Income Tax Expense | 2.69 | 2.51 | 1.71 | 0.77 | 0.58 | 0.98 |
Net Income | 7.88 | 7.36 | 4.97 | 2.13 | 1.71 | 2.9 |
Net Income to Common | 7.88 | 7.36 | 4.97 | 2.13 | 1.71 | 2.9 |
Net Income Growth | 40.68% | 47.99% | 133.18% | 24.96% | -41.18% | 88.44% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 0.88% | -0.35% | - | - | - | - |
EPS (Basic) | 1.44 | 1.35 | 0.91 | 0.39 | 0.31 | 0.53 |
EPS (Diluted) | 1.44 | 1.35 | 0.91 | 0.39 | 0.31 | 0.53 |
EPS Growth | 39.45% | 48.52% | 133.18% | 25.75% | -41.51% | 89.29% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1.73 | 0.97 | -4.17 | 5.43 | -1.12 |
Free Cash Flow Per Share | - | 0.32 | 0.18 | -0.76 | 0.99 | -0.20 |
Gross Margin | 72.30% | 68.89% | 67.29% | 82.91% | 70.81% | 100.00% |
Operating Margin | 11.79% | 12.19% | 11.55% | 7.59% | 13.85% | 15.25% |
Profit Margin | 9.04% | 9.35% | 8.69% | 6.14% | 10.99% | 12.12% |
Free Cash Flow Margin | - | 2.20% | 1.70% | -12.00% | 34.98% | -4.67% |
EBITDA | 10.32 | 9.63 | 6.65 | 2.66 | 2.17 | 3.68 |
EBITDA Margin | 11.84% | 12.24% | 11.62% | 7.65% | 13.94% | 15.37% |
D&A For EBITDA | 0.04 | 0.04 | 0.04 | 0.02 | 0.01 | 0.03 |
EBIT | 10.28 | 9.59 | 6.61 | 2.64 | 2.15 | 3.65 |
EBIT Margin | 11.79% | 12.19% | 11.55% | 7.59% | 13.85% | 15.25% |
Effective Tax Rate | 25.44% | 25.46% | 25.53% | 26.62% | 25.39% | 25.23% |
Revenue as Reported | 87.47 | 78.96 | 57.28 | 35.01 | 15.67 | 24.18 |